OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer - a ctDNA-guided phase II randomised approach. Study protocol.
Louise Bach CallesenTorben Frøstrup HansenRikke Fredslund AndersenNiels PallisgaardStine KramerSven SchlanderSøren Rafael RafaelsenAnders Kindberg BoysenLars Henrik JensenAnders JakobsenKaren-Lise Garm SpindlerPublished in: Acta oncologica (Stockholm, Sweden) (2022)